Accel Wealth Management’s Biogen BIIB Stock Holding History

Accel Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-137	Closed	-$38.1K	–	239
2023 Q1	$38.1K	Hold	137	–	–	0.02%	542
2022 Q4	$37.9K	Hold	137	–	–	0.02%	406
2022 Q3	$37K	Hold	137	–	–	0.02%	429
2022 Q2	$30K	Hold	137	–	–	0.02%	448
2022 Q1	$29K	Hold	137	–	–	0.02%	471
2021 Q4	$33K	Hold	137	–	–	0.02%	460
2021 Q3	$39K	Hold	137	–	–	0.03%	367
2021 Q2	$47K	Hold	137	–	–	0.03%	348
2021 Q1	$38K	Hold	137	–	–	0.03%	368
2020 Q4	$34K	Buy	+137	New	+$35.3K	0.03%	376

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Accel Wealth Management's BIIB Position: Q2 2023 in Review

Accel Wealth Management sold out of Biogen (BIIB) in Q2 2023, closing a stake of 137 shares — an estimated $38.1K sold.

Accel Wealth Management first reported a position in BIIB in Q4 2020 and held it in 10 quarters. The position peaked at $47K in Q2 2021. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Accel Wealth Management reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
Accel Wealth Management sold 137 Biogen shares in Q2 2023, an estimated $38.1K.
Accel Wealth Management first reported a position in Biogen in Q4 2020 and held it in 10 quarters.
Accel Wealth Management's Biogen position peaked at $47K in Q2 2021.
1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.